Decision Making Support for Parents and Caregivers

Sponsor
Duke University (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05733975
Collaborator
National Institutes of Health (NIH) (NIH), National Institute of Neurological Disorders and Stroke (NINDS) (NIH)
75
1
20.1

Study Details

Study Description

Brief Summary

The purpose of this study is to test the feasibility and acceptability of a tool to support decision making for parents of critically ill infants.

Condition or Disease Intervention/Treatment Phase
  • Other: Decision Making Guide
N/A

Detailed Description

The intervention includes a paper-based decision guide. This decision guide includes content related to decisional awareness, values clarification, and a series of question prompts that are directed toward guiding parents through health care decision making.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
75 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Other
Official Title:
Decision Making Support for Parents and Caregivers
Anticipated Study Start Date :
Mar 1, 2023
Anticipated Primary Completion Date :
May 1, 2024
Anticipated Study Completion Date :
Nov 1, 2024

Arms and Interventions

Arm Intervention/Treatment
Other: Use of Decision Making Tool

Single Arm design, study team will deliver the tool to be used by the parent(s) to help guide them in discussion with their infant's clinicians.

Other: Decision Making Guide
The tool will be used by parent(s) to help guide them in discussion with their infant's clinicians.

Outcome Measures

Primary Outcome Measures

  1. Intervention feasibility, as measured by enrollment rate greater than or equal to 50% [End of study, approximately 18 months]

  2. Intervention feasibility, as measured by complete data collection rate greater than or equal to 80% [End of study, approximately 18 months]

Secondary Outcome Measures

  1. Parent and clinician acceptability of the intervention as measured by an acceptability questionnaire [Up to 4 weeks following use of the tool]

    Acceptability will be measured using an acceptability questionnaire, consisting of close-ended and open-ended response items.

  2. Parent psychological distress, as measured by the Patient-Reported Outcomes Measurement Information System (PROMIS) [Baseline, and up to 4 weeks following use of the tool]

    PROMIS assesses the extent to which patients experience challenges with symptoms over the past 7 days using a 5-point Likert scale. Higher scores reflect greater symptom severity.

  3. Parent preparation for decision making, as measured by the PrepDM [Baseline, and up to 4 weeks following use of the tool]

    Items can be summed and scored. A higher score indicates higher perceived preparedness for decision making.

Eligibility Criteria

Criteria

Ages Eligible for Study:
1 Day to 1 Year
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No

Study participants will include English-speaking parents of critically ill infants and children admitted to Duke University Hospital.

Infant inclusion criteria will include

  1. age < 1 year,

  2. admission to a critical care unit, and

  3. an anticipated serious health care decision

All parents of eligible infants will be considered for inclusion. Parent exclusion criteria will include 1) age < 18 years, 2) hearing or speech impairment, and 3) non-English speakers.

All clinicians of eligible infants will be considered for inclusion.

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Duke University
  • National Institutes of Health (NIH)
  • National Institute of Neurological Disorders and Stroke (NINDS)

Investigators

  • Principal Investigator: Monica Lemmon, MD, Duke University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Duke University
ClinicalTrials.gov Identifier:
NCT05733975
Other Study ID Numbers:
  • Pro00111995
  • K23NS116453
First Posted:
Feb 17, 2023
Last Update Posted:
Feb 17, 2023
Last Verified:
Jan 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Feb 17, 2023